Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
832.4 EUR | -4.77% | +2.14% | +66.00% |
11:11am | ANALYST RECOMMENDATIONS : American Airlines, Chevron, UnitedHealth, Bank of America, Eli Lilly... | |
08:13am | Roche reports positive early results in obesity drug trial | RE |
Sales 2024 * | 42.99B 39.31B | Sales 2025 * | 52.8B 48.29B | Capitalization | 848B 775B |
---|---|---|---|---|---|
Net income 2024 * | 11.93B 10.91B | Net income 2025 * | 16.68B 15.25B | EV / Sales 2024 * | 20.2 x |
Net Debt 2024 * | 20.24B 18.5B | Net Debt 2025 * | 16.14B 14.76B | EV / Sales 2025 * | 16.4 x |
P/E ratio 2024 * |
70.4
x | P/E ratio 2025 * |
50.3
x | Employees | 43,000 |
Yield 2024 * |
0.55% | Yield 2025 * |
0.64% | Free-Float | 99.8% |
Latest transcript on Eli Lilly and Company
1 day | -4.67% | ||
1 week | +2.14% | ||
Current month | +2.80% | ||
1 month | +6.12% | ||
3 months | +24.40% | ||
6 months | +47.76% | ||
Current year | +66.00% |
Managers | Title | Age | Since |
---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 56 | 95-12-31 |
Ruth Gimeno
PSD | President | - | - |
David Hyman
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 63 | 21-01-24 | |
Ralph Alvarez
BRD | Director/Board Member | 68 | 09-03-31 |
Jon Fyrwald
BRD | Director/Board Member | 64 | 04-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-15 | 874 | +0.33% | 120 |
24-07-15 | 871.1 | +0.32% | 46 |
24-07-12 | 868.3 | +1.69% | 16 |
24-07-11 | 853.9 | -1.76% | 19 |
24-07-10 | 869.2 | +1.58% | 52 |
End-of-day quote Borsa Italiana, July 15, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.75% | 627B | |
-3.66% | 363B | |
+15.06% | 318B | |
+9.18% | 299B | |
+13.48% | 243B | |
+16.37% | 225B | |
+15.67% | 179B | |
+2.47% | 167B | |
+1.53% | 125B |
- Stock Market
- Equities
- LLY Stock
- 4LLY Stock